Utility Menu French

National Association of Pharmacy Regulatory Authorities

Provinces French

Main navigation French


Recherchez dans la base de données des Annexes nationales de médicaments

Commencez votre recherche en utilisant le nom générique du produit :

Recherche par annexe
Réinitialiser

ATTENTION : Tous les résultats de la recherche seront tirés du « National Drug Schedules » du site Web en anglais.

Nom du médicament (en anglais) Commentaire Annexe Date
MetoponN I JUN / 02
Metoprolol or its saltsPDL I DEC / 13
MetriboloneC3 I JUN / 02
MetronidazolePDL I DEC / 13
Metyrapone or its saltsPDL I DEC / 13
Mexiletine or its saltsPDL I DEC / 13
Mezlocillin or its salts or derivativesPDL

For veterinary use

I DEC / 13
MiboleroneC3 I JUN / 02
Micafungin or its saltsPDL I DEC / 13
Miconazole and its salts. for vaginal use III SEP / 98
Miconazole and its salts.. for topical use U
Miconazole or its saltsPDL

For human use - except in preparations for topical or vaginal.

I DEC / 13
Miconazole or its saltsPDL

For veterinary use.

I DEC / 13
Midazolam and its saltsTS I SEP / 98
Midodrine or its saltsPDL I DEC / 13
Midostaurin or its saltsPDL I SEP / 17
Mifepristone or its derivativesPDL I AUG / 15
Migalastat or its saltsPDL I DEC / 17
MiglustatPDL I DEC / 13
Milbemycin or its derivativesPDL

For veterinary use - including but not limited to Moxidectin. Moxidectin when sold for the prevention of heartworm in dogs.

I DEC / 13
Milbemycin or its derivativesPDL

For human use - including but not limited to moxidectin. 

I DEC / 13
Milrinone or its saltsPDL I DEC / 13
Mineral tar except shampoos with concentrations less than 5% III SEP / 98
MinoxidilPDL

For veterinary use

I DEC / 13
MinoxidilPDL

except when sold in preparations for topical use in concentrations of 5% or less, for human use only

I AUG / 14
Minoxidil.

when sold in preparations for topical use in adults in concentrations of 5% or less, for human use only

U JUL / 17
Mirabegron or its saltsPDL I DEC / 13
Mirtazapine or its saltsPDL I DEC / 13
Mitomycin or its saltsPDL I DEC / 13
MitotanePDL I DEC / 13
Mitoxantrone or its saltsPDL I DEC / 13
MitratapidePDL I FEB / 14
Mivacurium chloridePDL I DEC / 13
Moclobemide or its salts or derivativesPDL I DEC / 13
Modafinil or its saltsPDL I DEC / 13
MolgramostimPDL I DEC / 13
Mometasone furoateNR

For the treatment of allergic rhinitis in a nasal spray that delivers 50 mcg/spray for those 12 years of age and older.

I AUG / 15
Monobenzone II SEP / 98
Monoethanolamine oleate II SEP / 98
Montelukast or its saltsPDL I DEC / 13
MorpheridineN I JUN / 02
MorphineN I JUN / 02
Morphine-N-oxideN I JUN / 02
Moxifloxacin or its salts or derivativesPDL I DEC / 13
Mumps vaccine II DEC / 98
Mupirocin I SEP / 99
Muromonab-CD3PDL I DEC / 13
Mycophenolic acid or its salts or derivativesPDL

Including but not limited to Mycophenolate mofetil.

I DEC / 13
MyrophineN I JUN / 02

149 résultats


Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drugs Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled